Literature DB >> 10424735

Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.

T Brodowicz1, C Wiltschke, D Kandioler-Eckersberger, T W Grunt, M Rudas, S M Schneider, M Hejna, A Budinsky, C C Zielinski.   

Abstract

Uncontrolled proliferation and a defect of apoptosis constitute crucial elements in the development and progression of tumours. Among many other biological response modifiers known to influence these mechanisms, the efficacy of retinoids and interferons in the treatment of various malignant entities is currently matter of discussion. In the present study, we have investigated the effects of 9-cis-retinoic acid (9cRA), 13-cis-retinoic acid (13cRA), all-trans-retinoic acid (tRA) and interferon-alpha on proliferation and apoptosis of human soft tissue sarcoma (STS) cell lines HTB-82 (rhabdomyosarcoma), HTB-91 (fibrosarcoma), HTB-92 (liposarcoma), HTB-93 (synovial sarcoma) and HTB-94 (chondrosarcoma) in relation to p53 genotype as well as p53 expression. HTB-91, HTB-92 and HTB-94 STS cells exhibited mutant p53, whereas wild-type p53 was found in HTB-93 STS cells, and a normal p53 status in HTB-82 STS cells, carrying a silent point mutation only. Interferon-alpha, irrespective of p53 status, inhibited the proliferation of all five cell lines dose- and time-dependently. Similarly, 9cRA, 13cRA and tRA decreased the proliferation of HTB-82 and HTB-93 STS cells, whereas the proliferation of p53-mutated HTB-91, HTB-92 and HTB-94 STS cells remained unchanged. Furthermore, only 9cRA and tRA were capable of inducing apoptosis in HTB-82 and HTB-93 STS cells, whereas HTB-91, HTB-92 and HTB-94 STS cells did not undergo apoptosis under the influence of 9cRA or tRA. Retinoic acid receptor (RAR)-alpha and RAR-beta mRNA were not detectable by Northern blot analysis in the five STS cell lines, whereas mRNA for the universal retinoic acid receptor, RAR-gamma, was expressed in all STS cell lines indicating that retinoid resistance was not associated with a lack of RAR expression. Apoptosis was not induced by interferon-alpha or 13cRA in any of the five STS cell lines tested. Our results indicate that within the panel of tested STS cell lines, inhibition of proliferation and induction of apoptosis result from different mechanisms which differ in their dependence upon the presence of intact p53.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424735      PMCID: PMC2363080          DOI: 10.1038/sj.bjc.6690528

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.

Authors:  N Oridate; S Suzuki; M Higuchi; M F Mitchell; W K Hong; R Lotan
Journal:  J Natl Cancer Inst       Date:  1997-08-20       Impact factor: 13.506

2.  All-trans-retinoic acid in acute promyelocytic leukemia.

Authors:  M S Tallman; J W Andersen; C A Schiffer; F R Appelbaum; J H Feusner; A Ogden; L Shepherd; C Willman; C D Bloomfield; J M Rowe; P H Wiernik
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

Review 3.  Adjuvant therapy of sarcomas of soft tissue.

Authors:  K H Antman
Journal:  Semin Oncol       Date:  1997-10       Impact factor: 4.929

4.  Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

Authors:  T Brodowicz; R Kotz; C Wiltschke; C C Zielinski; P Ritschl
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

5.  Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.

Authors:  J J Ryan; R Danish; C A Gottlieb; M F Clarke
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

6.  An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

Authors:  K Antman; J Crowley; S P Balcerzak; S E Rivkin; G R Weiss; A Elias; R B Natale; R M Cooper; B Barlogie; D L Trump
Journal:  J Clin Oncol       Date:  1993-07       Impact factor: 44.544

7.  Retinoic acid receptor-gamma in human epidermis preferentially traps all-trans retinoic acid as its ligand rather than 9-cis retinoic acid.

Authors:  G J Fisher; S C Datta; J J Voorhees
Journal:  J Invest Dermatol       Date:  1998-03       Impact factor: 8.551

8.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

9.  All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.

Authors:  G D Crouch; L J Helman
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

10.  An outpatient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies.

Authors:  R Rosso; M R Sertoli; P Queirolo; O Sanguineti; M C Barzacchi; G L Mariani; L Miglio; M Venturini; S Toma
Journal:  Ann Oncol       Date:  1992-07       Impact factor: 32.976

View more
  8 in total

Review 1.  Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.

Authors:  Qing Wu; Wei Qian; Xiaoli Sun; Shaojie Jiang
Journal:  J Hematol Oncol       Date:  2022-10-08       Impact factor: 23.168

2.  Vaccination using peptides spanning the SYT-SSX tumor-specific translocation.

Authors:  Jordan E Bloom; Douglas G McNeel; Brian M Olson
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

3.  A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.

Authors:  Adele P Williams; Alicia M Waters; Jerry E Stewart; Venkatram R Atigadda; Elizabeth Mroczek-Musulman; Donald D Muccio; Clinton J Grubbs; Elizabeth A Beierle
Journal:  J Surg Res       Date:  2018-03-26       Impact factor: 2.192

Review 4.  Solid tumor differentiation therapy - is it possible?

Authors:  Filemon Dela Cruz; Igor Matushansky
Journal:  Oncotarget       Date:  2012-05

5.  Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.

Authors:  T Brodowicz; D Kandioler; S Tomek; C Ludwig; M Rudas; R Kunstfeld; W Koestler; M Hejna; A Budinsky; C Wiltschke; C C Zielinski
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

6.  Enhanced antitumor effect of ultrasound in the presence of piroxicam in a mouse air pouch model.

Authors:  Kyoji Okada; Eiji Itoi; Naohisa Miyakoshi; Mizuho Nakajima; Toshio Suzuki; Jun Nishida
Journal:  Jpn J Cancer Res       Date:  2002-02

Review 7.  Engaging plasticity: Differentiation therapy in solid tumors.

Authors:  Neta Bar-Hai; Dana Ishay-Ronen
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

8.  Effects of retinoic acid isomers on apoptosis and enzymatic antioxidant system in human breast cancer cells.

Authors:  Tae-Kyong Hong; Yang Cha Lee-Kim
Journal:  Nutr Res Pract       Date:  2009-06-30       Impact factor: 1.926

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.